(***) Products for Pain: Ineffective, Expensive, and With Potential Harms

Buy Lab Tests Online

Deleted member 43589

Well-Known Member
Well folks, This pretty well sums up what I believe after using quite a few different product to relieve pain.

Highlights​


  • Cannabidiol (***) products have varying amounts of ***, from none to much more than advertised.

  • *** products may contain other chemicals than ***, some of which may be harmful.

  • Sixteen RCTs for pain used pharmaceutical *** in oral, buccal/sublingual, and topical forms.

  • Fifteen of the 16 RCTs were negative: no greater pain-relieving effect for *** than for placebo.

  • Meta-analyses link *** to increased rates of serious adverse events and hepatotoxicity.

Abstract​

Cannabidiol (***) attracts considerable attention for promoting good health and treating various conditions, predominantly pain, often in breach of advertising rules. Examination of available *** products in North America and Europe demonstrates that *** content can vary from none to much more than advertised and that potentially harmful other chemicals are often included. Serious harm is associated with chemicals found in *** products and reported in children, adults, and the elderly. A 2021 International Association for the Study of Pain task force examined the evidence for cannabinoids and pain but found no trials of ***. Sixteen *** randomized trials using pharmaceutical-supplied *** or making preparations from such a source and with pain as an outcome have been published subsequently. The trials were conducted in 12 different pain states, using 3 oral, topical, and buccal/sublingual administration, with *** doses between 6 and 1,600 mg, and durations of treatment between a single dose and 12 weeks. Fifteen of the 16 showed no benefit of *** over placebo. Small clinical trials using verified *** suggest the drug to be largely benign; while large-scale evidence of safety is lacking, there is growing evidence linking *** to increased rates of serious adverse events and hepatotoxicity. In January 2023, the Food and Drug Administration (FDA) announced that a new regulatory pathway for *** was needed. Consumers and health care providers should rely on evidence-based sources of information on ***, not just advertisements. Current evidence is that *** for pain is expensive, ineffective, and possibly harmful.

Perspective​

There is no good reason for thinking that *** relieves pain, but there are good reasons for doubting the contents of *** products in terms of *** content and purity.

 
Defy Medical TRT clinic doctor
Beyond Testosterone Book by Nelson Vergel
It's crucial to have honest discussions about *** products, especially when it comes to pain relief. The inconsistency in *** content and the presence of potentially harmful chemicals are definitely concerning.
 
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

bodybuilder test discounted labs
cheap enclomiphene
TRT in UK Balance my hormones
Discounted Labs
Testosterone Doctor Near Me
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
BUY HCG CIALIS

Online statistics

Members online
5
Guests online
8
Total visitors
13

Latest posts

Top